Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agents.
Tashkin
Donald P
DP
David Geffen School of Medicine, Division of Pulmonary and Critical Care Medicine, UCLA, Los Angeles, California, USA. dtashkin@mednet.ucla.edu
Fabbri
Leonardo M
LM
D000280:Administration, Inhalation; D058666:Adrenergic beta-2 Receptor Agonists / Q000008:administration & dosage*; D001993:Bronchodilator Agents / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D005544:Forecasting; D006801:Humans; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy*
D058666:Adrenergic beta-2 Receptor Agonists; D001993:Bronchodilator Agents